To determine human immunodeficiency virus-1 (HIV-1) prevalence in low-
and high-risk populations in Papua New Guinea (PNG), anonymous unlink
ed serosurveillance was conducted in government-administered antenatal
and sexually transmitted disease (STD) clinics at six sites beginning
in June 1989. Although 3 of 1233 samples were HIV positive in a pilot
study, none of 7948 samples was HIV positive during the first full ye
ar of serosurveillance (June 1989 - May 1990). HIV-infected people are
also identified in PNG through clinical diagnostic testing. Although
underreporting is probably substantial, 45 HIV-infected people had bee
n identified in PNG (population 3.6 million) through diagnostic testin
g between 1987 and the end of the first serosurveillance year (May 199
0). In view of the steadily emerging clinical problem of acquired immu
ne deficiency syndrome (AIDS) in PNG, the negative results of serosurv
eillance required explanation. Three possibilities are proposed: 1) th
e sample size chosen could fail to detect a case 5 % (or more) of the
time under the likely conditions of this survey; 2) the populations ch
osen for surveillance may not, yet, be those in which HIV is circulati
ng at this early stage of the epidemic in PNG; and 3) laboratory error
could account for some false negative results. The first two of these
, alone or in combination, are most likely. Limited surveillance conti
nued in PNG in 1991 and 1992. By June of 1992, 5 of an additional 6035
serosurveillance samples had tested positive. All 5 were among 2000 s
amples from a single site, the Port Moresby STD Clinic. In addition to
surveillance, further clinical diagnostic testing had identified a to
tal of 118 HIV-infected people by June of 1992. While AIDS has clearly
made its presence felt in Papua New Guinea, overall HIV prevalence ap
pears low. A high incidence of STDs, particularly of genital ulcerativ
e conditions, suggests the potential for rapid dissemination of HIV in
Papua New Guinea over the next several years.